All 258 BIB (PROSHARES ULTRA NASDAQ BIOTECHNOLOGY) Holdings
There are 258 BIB holdings. Top 10 companies weight: 60.91%.
Total Market Cap: $1.73T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (258 stocks) | +18.25% | 21.12 | 15.78 | 0.45 | +28.27% | +9.30% | 0.76 | ||||||||||
1 | n/a | Nasdaq Biotechnology Index Swap | 21.23% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
2 | n/a | Cash | 9.46% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
3 | IQMM | Proshares Genius Money Market Etf | 5.98% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
4 | VRTX | Vertex Pharmaceuticals Inc | 4.57% | $480.50 | $121B | Biotechnology | Healthcare | +9.89% | 27.99 | 25.45 | 1.72 | N/A | N/A | 72 | +15.39% | $554 | +19.61% | 0.49 |
5 | AMGN | Amgen Inc | 4.41% | $364.17 | $193B | Drug Manufacturers - General | Healthcare | +3.49% | 24.75 | 16.47 | 0.79 | N/A | N/A | 60 | -2.07% | $357 | +11.73% | 0.46 |
6 | n/a | Nasdaq Bio Index Swap | 3.97% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
7 | GILD | Gilead Sciences Inc | 3.85% | $133.21 | $164B | Drug Manufacturers - General | Healthcare | +98.59% | 17.75 | 15.22 | 0.32 | N/A | N/A | 74 | +18.83% | $158 | +18.49% | 0.35 |
8 | n/a | Cte Proshares Trust M | 3.34% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
9 | REGN | Regeneron Pharmaceuticals Inc | 2.52% | $672.15 | $69B | Biotechnology | Healthcare | +20.31% | 15.86 | 15.08 | 88.04 | N/A | N/A | 72 | +21.87% | $819 | +3.03% | 0.60 |
10 | ALNY | Alnylam Pharmaceuticals Inc | 1.58% | $272.67 | $37B | Biotechnology | Healthcare | N/A | 117.96 | 30.49 | 0.52 | N/A | N/A | 74 | +59.47% | $435 | +8.65% | 0.81 |
11 | RVMD | Revolution Medicines Inc Ordinary Shares | 1.56% | $180.39 | $37B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +11.15% | $201 | +42.94% | 1.09 |
12 | BIIB | Biogen Inc | 1.21% | $199.95 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.41 | 14.75 | 0.64 | N/A | N/A | 65 | +13.17% | $226 | -9.14% | 0.51 |
13 | MRNA | Moderna Inc | 1.13% | $59.49 | $27B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 46 | -18.88% | $48 | -28.62% | 1.37 |
14 | ILMN | Illumina Inc | 1.09% | $184.68 | $29B | Diagnostics & Research | Healthcare | -6.80% | 44.12 | 35.59 | 3.34 | N/A | N/A | 60 | -9.23% | $168 | -16.96% | 1.00 |
15 | ROIV | Roivant Sciences Ltd Ordinary Shares | 0.99% | $34.05 | $25B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +15.48% | $39 | 0.00% | 0.90 |
16 | ARGX | Argenx Se Adr | 0.98% | $846.19 | $57B | Biotechnology | Healthcare | N/A | 24.30 | 32.89 | 0.21 | N/A | N/A | 79 | +24.69% | $1.06K | +21.54% | 0.46 |
17 | RPRX | Royalty Pharma Plc Class A | 0.97% | $57.30 | $25B | Biotechnology | Healthcare | N/A | 28.69 | 48.08 | 1.32 | N/A | N/A | 75 | +4.53% | $60 | +9.29% | 0.25 |
18 | UTHR | United Therapeutics Corp | 0.91% | $529.34 | $22B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 17.96 | 19.49 | 1.91 | N/A | N/A | 75 | +25.34% | $663 | +23.70% | 0.41 |
19 | INSM | Insmed Inc | 0.91% | $107.02 | $24B | Biotechnology | Healthcare | +12.24% | N/A | 16.37 | 1.09 | N/A | N/A | 80 | +83.50% | $196 | +32.69% | 0.77 |
20 | GH | Guardant Health Inc | 0.89% | $148.07 | $21B | Diagnostics & Research | Healthcare | +1.05% | N/A | N/A | N/A | N/A | N/A | 77 | +15.54% | $171 | +4.43% | 1.17 |
21 | INCY | Incyte Corp | 0.89% | $115.65 | $23B | Biotechnology | Healthcare | +27.16% | 15.82 | 15.06 | N/A | N/A | N/A | 61 | -1.58% | $114 | +7.88% | 0.57 |
22 | VTRS | Viatris Inc | 0.74% | $16.99 | $19B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 7.02 | 0.14 | N/A | N/A | 60 | +4.83% | $18 | +8.31% | 0.79 |
23 | NBIX | Neurocrine Biosciences Inc | 0.66% | $173 | $17B | Drug Manufacturers - Specialty & Generic | Healthcare | +9.25% | 25.72 | 24.10 | 0.21 | N/A | N/A | 75 | +15.75% | $200 | +12.11% | 0.79 |
24 | ASND | Ascendis Pharma As | 0.65% | $251.76 | $17B | Biotechnology | Healthcare | N/A | 30.09 | 16.39 | N/A | N/A | N/A | 80 | +19.78% | $302 | +15.59% | 0.44 |
25 | MEDP | Medpace Holdings Inc | 0.61% | $527.93 | $15B | Diagnostics & Research | Healthcare | +29.42% | 32.55 | 31.95 | 1.67 | N/A | N/A | 57 | -10.53% | $472 | +23.67% | 1.00 |
26 | JAZZ | Jazz Pharmaceuticals Plc | 0.58% | $243.47 | $15B | Biotechnology | Healthcare | N/A | N/A | 13.51 | 0.96 | N/A | N/A | 78 | +7.51% | $262 | +6.61% | 0.72 |
27 | BBIO | Bridgebio Pharma Inc | 0.57% | $80.76 | $16B | Biotechnology | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 79 | +29.74% | $105 | +5.57% | 1.02 |
28 | EXEL | Exelixis Inc | 0.53% | $55.53 | $14B | Biotechnology | Healthcare | +72.24% | 17.54 | 17.70 | 0.45 | N/A | N/A | 59 | -8.28% | $51 | +26.67% | 0.52 |
29 | IONS | Ionis Pharmaceuticals Inc | 0.51% | $52.95 | $9.08B | Biotechnology | Healthcare | -21.44% | N/A | 90.91 | N/A | N/A | N/A | 79 | +75.54% | $93 | +7.60% | 0.65 |
30 | AXSM | Axsome Therapeutics Inc | 0.48% | $221.64 | $12B | Biotechnology | Healthcare | +6.89% | N/A | 333.33 | N/A | N/A | N/A | 77 | +26.51% | $280 | +31.16% | 0.66 |
31 | MDGL | Madrigal Pharmaceuticals Inc | 0.47% | $535.69 | $13B | Biotechnology | Healthcare | +23.26% | N/A | 666.67 | N/A | N/A | N/A | 76 | +26.73% | $679 | +41.75% | 0.76 |
32 | CYTK | Cytokinetics Inc | 0.45% | $79.11 | $10B | Biotechnology | Healthcare | +27.73% | N/A | 117.65 | N/A | N/A | N/A | 80 | +36.27% | $108 | +21.99% | 0.77 |
33 | BMRN | Biomarin Pharmaceutical Inc | 0.44% | $59.11 | $11B | Biotechnology | Healthcare | -20.33% | 42.21 | 11.96 | 0.73 | N/A | N/A | 75 | +48.81% | $88 | -5.79% | 0.65 |
34 | SMMT | Summit Therapeutics Inc Ordinary Shares | 0.44% | $13.50 | $12B | Biotechnology | Healthcare | N/A | N/A | 3.72 | N/A | N/A | N/A | 60 | +113.33% | $29 | +12.03% | 1.75 |
35 | ARWR | Arrowhead Pharmaceuticals Inc | 0.44% | $71.65 | $10B | Biotechnology | Healthcare | +15.23% | N/A | 111.11 | N/A | N/A | N/A | 78 | +33.98% | $96 | +1.03% | 1.63 |
36 | KRYS | Krystal Biotech Inc | 0.43% | $339.22 | $10B | Biotechnology | Healthcare | N/A | 45.34 | 46.95 | 0.57 | N/A | N/A | 72 | +6.62% | $362 | +39.91% | 0.92 |
37 | BNTX | Biontech Se Adr | 0.43% | $92.16 | $23B | Biotechnology | Healthcare | N/A | N/A | 7.04 | N/A | N/A | N/A | 70 | +32.63% | $122 | -18.34% | 0.94 |
38 | TEM | Tempus Ai Inc Class A Common Stock | 0.42% | $48.41 | $10B | Health Information Services | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 65 | +38.53% | $67 | 0.00% | 2.68 |
39 | IBRX | Immunitybio Inc Ordinary Shares | 0.38% | $7.50 | $8.10B | Biotechnology | Healthcare | -9.78% | N/A | N/A | N/A | N/A | N/A | 83 | +73.45% | $13 | -8.69% | 1.56 |
40 | SNY | Sanofi Sa Adr | 0.38% | $43.98 | $105B | Drug Manufacturers - General | Healthcare | -8.34% | 12.12 | 9.07 | 0.39 | N/A | N/A | 62 | +25.19% | $55 | +1.15% | 0.31 |
41 | ONC | Beone Medicines Ltd Adr | 0.38% | $310.58 | $36B | Biotechnology | Healthcare | N/A | 69.54 | 47.39 | N/A | N/A | N/A | 81 | +33.57% | $415 | +0.26% | 0.54 |
42 | KYMR | Kymera Therapeutics Inc Ordinary Shares | 0.37% | $111.06 | $9.38B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +12.68% | $125 | +14.19% | 1.52 |
43 | NUVL | Nuvalent Inc Class A | 0.36% | $123.96 | $9.75B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 50 | +0.03% | $124 | 0.00% | 0.97 |
44 | HALO | Halozyme Therapeutics Inc | 0.36% | $77.09 | $8.99B | Biotechnology | Healthcare | +20.06% | 25.62 | 10.78 | N/A | N/A | N/A | 67 | +8.83% | $84 | +12.87% | 0.62 |
45 | PRAX | N/A | 0.35% | $304.43 | $8.87B | Biotechnology | Healthcare | -18.18% | N/A | N/A | N/A | N/A | N/A | 75 | +100.39% | $610 | +3.11% | 0.93 |
46 | ALKS | Alkermes Plc | 0.34% | $51.72 | $8.65B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 56.04 | 136.99 | 1.96 | N/A | N/A | N/A | N/A | N/A | +16.50% | N/A |
47 | PCVX | Vaxcyte Inc Ordinary Shares | 0.32% | $55.50 | $8.19B | Biotechnology | Healthcare | +33.90% | N/A | N/A | N/A | N/A | N/A | 75 | +96.40% | $109 | +18.66% | 0.73 |
48 | PTGX | Protagonist Therapeutics Inc | 0.32% | $134.27 | $8.70B | Biotechnology | Healthcare | +1.43% | N/A | 29.85 | N/A | N/A | N/A | 78 | -6.79% | $125 | +22.86% | 0.21 |
49 | APGE | Apogee Therapeutics Inc | 0.32% | $134.15 | $10B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 69 | -2.70% | $131 | 0.00% | 1.25 |
50 | IMVT | Immunovant Inc | 0.31% | $39.92 | $8.13B | Biotechnology | Healthcare | +18.52% | N/A | N/A | N/A | N/A | N/A | 70 | +18.21% | $47 | +31.90% | 1.21 |
BIB (PROSHARES ULTRA NASDAQ BIOTECHNOLOGY) Sector Allocation
HEALTHCARE
53.00%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%